secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartBeam, Inc. (BEAT)
CIK:        0001779372
Form:       8-K
Filed at:   2022-02-02T23:59:59+00:00
Accession:  0001779372-22-000005
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 1.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartBeam partners with LIVMOR for RPM platform; terminates Ximedica deal
-------------------------------------------------------------------------

- Partnered with LIVMOR to build HeartBeam-branded version of LIVMOR's FDA-cleared Halo+ RPM portal for physicians and patients.
- Terminated prior development agreement with Ximedica, effective January 31, 2022, to proceed with LIVMOR partnership.
- Customized HeartBeam Platform intended to support FDA submission of heart attack detection software for ED settings later in 2022.
- Development fees paid in two equal installments; term of three years with automatic renewal unless terminated.
- Senior executives of both companies will supervise the project; LIVMOR provides regulatory support for FDA clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779372/000177937222000005/0001779372-22-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779372/000177937222000005/beat-20220131.htm
  HTML page:      https://secwatch.observer/filing/0001779372-22-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer